search
Back to results

Polyamine-free Diet to Prevent Post Surgery Hyperalgesia (PoLyDOL)

Primary Purpose

Breast Cancer, Surgery

Status
Completed
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
polyamine-free diet
Ketamine or placebo
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer focused on measuring polyamines, pain, breast cancer, mastectomy, post operative pain

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Breast cancer (T1, T2, T3, N0, N1, M0) Age : 18 - 75 Asa 1-3 left or right tumorectomy with complete lymphadenectomy left or right complete mastectomy with complete lymphadenectomy complete lymphadenectomy within one week following simple tumorectomy informed consent signed Exclusion Criteria: inflammatory tumor requiring pre-operative radiotherapy previous history of total mastectomy or partial contralateral mastectomy chronic inflammatory disease treated by corticoids or NSAI chronic analgesic treatment anti-arrhythmic or anti-epileptic treatments morphinic treatment during the 7 days before surgery excessive alcohol consumption or addiction ketamine or neomycin contra-indication severe cardiovascular disease

Sites / Locations

  • CLCC-Institut Bergonie, service d'anesthésie réanimation, 229 cours de l'Argonne
  • département d'anesthésie-réanimation 3, hôpital Pellegrin
  • CLCC Alexis Vautrin
  • APHParis Hôpital Pitié Salpétrière - Dépt. d'anesthésie réanimation
  • CLCC Réné Huguenin de Saint Cloud

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

R+ / K+

R+ / K-

R- / K+

R- /K-

Arm Description

Outcomes

Primary Outcome Measures

Morphine requirement

Secondary Outcome Measures

Pain intensity for the 4 days (and possibly at 7th day if the patient is still hospitalized) after surgery
Allodynia measurements
Hyperesthesia measurements
Chronic pain incidence
Late allodynia and/or hyperesthesia
safety of treatment

Full Information

First Posted
March 17, 2006
Last Updated
December 24, 2009
Sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France, Insurance CNP foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00304850
Brief Title
Polyamine-free Diet to Prevent Post Surgery Hyperalgesia
Acronym
PoLyDOL
Official Title
Efficacy of a Polyamine-free Diet Associated or Not With Ketamine on Early and Late Hyperalgesia After Breast Cancer Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
December 2009
Overall Recruitment Status
Completed
Study Start Date
March 2006 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
May 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Bordeaux
Collaborators
Ministry of Health, France, Insurance CNP foundation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
After surgery, sensitization and hyperexcitability of central nervous system result in acute and long lasting postoperative pain. It has been shown that N-methyl-D-aspartate (NMDA) receptors antagonist (such as ketamine) prevent this adverse neuroplasticity and potentiate analgesic drugs efficacy. Polyamines (putrescine, spermidine, spermine) are essential components of cells functioning and are also known as allosteric modulators of NMDA receptors. In animal studies, polyamine-free diet has confirmed these antinociceptive properties. This research aims at evaluating anti hyperalgesic properties of polyamine-free diet in women operated on breast cancer versus kétamine
Detailed Description
This multicentric, single blind study will enrol 160 women (18-75 years old) operated on tumorectomy and adenectomy (T1, T2, T3, N0, N1, M0) for breast cancer. Patients will be randomly assigned in a 2x2 factorial plan : Group 1 = control (n = 40) ; group 2 = ketamine group administered during and 48 hours after a standardized anesthesia (n = 40) ; group 3 = polyamine-free diet, 1 week and 72 hours after surgery (n = 40) ; group 4 : ketamine + polyamine-free diet (n = 40). The amount of morphine for the 24 first postoperative hours will be compared between each group as well as pain score, allodynia (Von Frey filaments) and hyperalgesia (algometer). Chronic pain occurrence (post-mastectomy pain syndrome) will be evaluated at 3 and 6 months using adequate questionnaire ( analgesic scale). Diet observance will be controlled preoperatively by a dosage of polyamines in circulating red cells blood. Polyamines deprivation and ketamine ability to reduce postoperative pain will be compared (isobolographic method). Anti-hyperalgesic properties of ketamine have already been demonstrated in urologic, orthopaedic and abdominal surgery. In case of additive or synergistic effect of a polyamine deprivation such a strategic could be helpful to achieve better postoperative rehabilitation in reducing chronic pain after surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Surgery
Keywords
polyamines, pain, breast cancer, mastectomy, post operative pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
160 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
R+ / K+
Arm Type
Experimental
Arm Title
R+ / K-
Arm Type
Experimental
Arm Title
R- / K+
Arm Type
Experimental
Arm Title
R- /K-
Arm Type
Placebo Comparator
Intervention Type
Behavioral
Intervention Name(s)
polyamine-free diet
Intervention Description
Polyamine-free diet in the 7 days befor surgery
Intervention Type
Drug
Intervention Name(s)
Ketamine or placebo
Intervention Description
Peroperative and post operative (48h) ketamine injection
Primary Outcome Measure Information:
Title
Morphine requirement
Time Frame
for the 24 postoperative hours
Secondary Outcome Measure Information:
Title
Pain intensity for the 4 days (and possibly at 7th day if the patient is still hospitalized) after surgery
Time Frame
4 days
Title
Allodynia measurements
Time Frame
inclusion, 1, 2, 4 and 7 ddays after surgery
Title
Hyperesthesia measurements
Time Frame
inclusion, 1, 2, 4 and 7 ddays after surgery
Title
Chronic pain incidence
Time Frame
3 and 6 months
Title
Late allodynia and/or hyperesthesia
Time Frame
6 months
Title
safety of treatment
Time Frame
Along each patient folow-up

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Breast cancer (T1, T2, T3, N0, N1, M0) Age : 18 - 75 Asa 1-3 left or right tumorectomy with complete lymphadenectomy left or right complete mastectomy with complete lymphadenectomy complete lymphadenectomy within one week following simple tumorectomy informed consent signed Exclusion Criteria: inflammatory tumor requiring pre-operative radiotherapy previous history of total mastectomy or partial contralateral mastectomy chronic inflammatory disease treated by corticoids or NSAI chronic analgesic treatment anti-arrhythmic or anti-epileptic treatments morphinic treatment during the 7 days before surgery excessive alcohol consumption or addiction ketamine or neomycin contra-indication severe cardiovascular disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre MAURETTE, Pr
Organizational Affiliation
DAR 3 -Pellegrin hospital-33076 Bordeaux - France
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Genevieve CHENE, Pr
Organizational Affiliation
University hospital - 33076 Bordeaux - France
Official's Role
Study Chair
Facility Information:
Facility Name
CLCC-Institut Bergonie, service d'anesthésie réanimation, 229 cours de l'Argonne
City
Bordeaux
ZIP/Postal Code
33000
Country
France
Facility Name
département d'anesthésie-réanimation 3, hôpital Pellegrin
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Facility Name
CLCC Alexis Vautrin
City
Nancy
ZIP/Postal Code
54511
Country
France
Facility Name
APHParis Hôpital Pitié Salpétrière - Dépt. d'anesthésie réanimation
City
Paris
ZIP/Postal Code
75013
Country
France
Facility Name
CLCC Réné Huguenin de Saint Cloud
City
Saint Cloud
ZIP/Postal Code
92210
Country
France

12. IPD Sharing Statement

Learn more about this trial

Polyamine-free Diet to Prevent Post Surgery Hyperalgesia

We'll reach out to this number within 24 hrs